UPDATE: Intra-Cellular Therapies stock soars 83% premarket after FDA approves schizophrenia treatment - MarketWatch

UPDATE: Intra-Cellular Therapies stock soars 83% premarket after FDA approves schizophrenia treatment  MarketWatch

Comments

Popular posts from this blog

CT's Lindsey Jacobellis wins Team USA's first gold medal at Beijing Games with victory in women's snowboard cross - WFSB